Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Candid Therapeutics logo

Candid Therapeutics

Recent Finacing

Equity

Recent Raise

$505M

Candid Therapeutics is a clinical-stage biotechnology company developing T-cell engager therapies to treat autoimmune diseases.

Founded 2024
California, United States
11-50
Private
candidrx.com
PitchBook

Highlights

Focus Areas

Biotechnology
Product Research
Therapeutics

Recent Investors

Soleus Capital logo
venBio Partners logo
TCGX logo
Foresite Capital logo
Venrock logo
T. Rowe Price Associates logo
Viking Global Investors logo
RA Capital Management logo
Janus Henderson Investors logo
Cormorant Asset Management logo
Vivo Capital logo
Third Rock Ventures logo

Financials

$875M

Total Raised

2

Funding rounds

18

Investors


Team

Upgrade to view the team

See the team members at Candid Therapeutics.